Cross Infection: Clinical Trials

35 trials for Cross Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed. 35 Phase 2, 6 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 235Completed 35
Phase 36Completed 6
Phase 14Completed 4

Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oro-nasal Decontamination to Prevent Ventilator-associated Pneumonia
Povidone-Iodine, Saline spray - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedMenoufia University782023-06-242023-11-27
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
BV100 plus Polymyxin B, BAT - Ventilator Associated Pneumonia
Phase 2CompletedBioVersys AG392023-04-202025-01-14
Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
Anakinra Prefilled Syringe, Placebo - Community-acquired Pneumonia, Hospital-acquired Pneumonia
Phase 2CompletedHellenic Institute for the Study of Sepsis602023-03-062024-07-31
Red Light Photobiomodulation and Topical Disinfectants
Methylene Blue Only, Chlorhexidine Gluconate Only, Methylene Blue + Chlorhexidine Gluconate - Healthcare Associated Infection, Nosocomial Infection
Phase 1 / Phase 2CompletedOndine Biomedical Inc.282023-01-102023-04-04
Intravenous Metoprolol in Septic Shock
Intravenous metoprolol tartrate, Standard Care (in control arm) - Septic Shock, Ventilator Acquired Pneumonia
Phase 2CompletedAlexandria University1002022-04-012025-01-29
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection
Phase 2CompletedOndine Biomedical Inc.3222022-02-042022-08-22
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants
Cefiderocol, Standard of Care - Gram-negative Bacterial Infections, Bloodstream Infections (BSI)
Phase 2CompletedShionogi532020-08-212026-02-27
Inulin for Infections in the Intensive Care Unit
Inulin Oral Suspension, Placebo Oral Suspension, Broad-spectrum antibiotics - Antibiotic Resistant Infection, Nosocomial Infection
Phase 2CompletedColumbia University942019-10-142025-06-19
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
EVAC-PU-ETT, PVC-ETT - Ventilator-acquired Pneumonia
Phase 2CompletedYale University10742019-05-062024-09-24
Coated Devices to Decrease Infection in the Intensive Care Unit
Coated devices, Control - Critically Ill
Phase 1 / Phase 2CompletedHospital do Coracao1032019-04-062020-03-09
Low Versus High Corticosteroid Use in Ventilator Associated Pneumonia
methylprednisolone, Methyl Prednisolonate, ventilators - Ventilator Associated Pneumonia
Phase 2CompletedKing Abdul Aziz Specialist Hospital2402018-01-022020-07-13
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
Colistin, Carbapenem + Aminoglycoside/ Quinolone - Ventilator Associated Pneumonia
Phase 2 / Phase 3CompletedNourhan Hassan Osama Thuraya Mohamed402016-01-022018-08-09
Atropine for Preventing Ventilator-Associated Pneumonia
Atropine, Placebo - Ventilator-Associated Pneumonia
Phase 2CompletedUniversidade de Passo Fundo402015-02-012016-03-10
Clinical Trial Evaluating Chlorine e6 Derivative-mediated Antimicrobial Photodynamic Therapy as a Treatment for Denture Stomatitis
Nystatin, Antimicrobial Photodynamic Therapy - Health Care Associated Infection
Phase 2CompletedSão Paulo State University652015-02-012020-08-31
Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)
Chlorhexidine, 0.9% sodium chloride injection, Endotracheal tube - Ventilator-associated Pneumonia
Phase 2CompletedGeneral Hospital of Shenyang Military Region1922014-03-012019-08-14
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
POL7080 - Ventilator Associated Pneumonia, Lower Respiratory Infection
Phase 2CompletedPolyphor Ltd.252013-10-012017-11-28
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
L. rhamnosus GG - Probiotic, Placebo - Microcrystalline Cellulose - Ventilator Associated Pneumonia (VAP), Other Infections
Phase 2CompletedMcMaster University1502013-10-012019-08-28
Vitamin D in Ventilated ICU Patients
Enteral Vitamin D3 50,000 IU, Enteral Vitamin D3 100,000IU, Inactive substance - Respiratory Failure
Phase 2CompletedEmory University312011-07-012017-01-09
Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules
cranberry type A pro anthocyandines, Placebo - Cross Infection, Bacteriuria
Phase 2CompletedCentre Hospitalier Universitaire de Nīmes2702010-08-012025-11-17
Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients
IC43, Placebo - Pneumonia, Ventilator-Associated
Phase 2CompletedValneva Austria GmbH4002008-12-012012-10-19

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Pneumonia, Ventilator-Associated (22)  ·  Pneumonia (11)  ·  Infections (5)  ·  Sepsis (5)  ·  Healthcare-Associated Pneumonia (4)  ·  Pseudomonas Infections (4)  ·  Surgical Wound Infection (4)  ·  Bacterial Infections (3)  ·  Critical Illness (3)  ·  Fever (2)  ·  Pneumonia, Bacterial (2)  ·  Respiratory Tract Infections (2)  ·  Abdominal Abscess (1)  ·  Bacteriuria (1)

Broader conditions

Disease Attributes (35)  ·  Iatrogenic Disease (35)  ·  Pathologic Processes (35)  ·  Pathological Conditions, Signs and Symptoms (35)  ·  Infections (30)  ·  Respiratory Tract Diseases (27)  ·  Lung Diseases (25)  ·  Respiratory Tract Infections (24)  ·  Healthcare-Associated Pneumonia (19)  ·  Pneumonia (14)  ·  Bacterial Infections and Mycoses (9)  ·  Inflammation (7)  ·  Bacterial Infections (6)  ·  Systemic Inflammatory Response Syndrome (6)

Interventions

Chlorhexidine (2)  ·  Doripenem (2)  ·  Standard of Care (2)  ·  chlorhexidine gluconate (2)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  Amikacin (1)  ·  Aminoglycosides (1)  ·  Anti-Bacterial Agents (1)  ·  Atropine (1)  ·  Carbapenems (1)  ·  Cefiderocol (1)  ·  Ceftazidime (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Ciprofloxacin (1)  ·  ClinOleic (1)

Sponsors

Emory University (2)  ·  Ondine Biomedical Inc. (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Alexandria University (1)  ·  BioVersys AG (1)  ·  Canadian Critical Care Trials Group (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Columbia University (1)  ·  General Hospital of Shenyang Military Region (1)  ·  Groupe Hospitalier Pitie-Salpetriere (1)  ·  Hellenic Institute for the Study of Sepsis (1)  ·  Hospital do Coracao (1)  ·  Humanigen, Inc. (1)  ·  Johns Hopkins University (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

Countries

United States (14)  ·  France (4)  ·  Canada (3)  ·  Greece (3)  ·  Egypt (2)  ·  Georgia (2)  ·  Hungary (2)  ·  Russia (2)  ·  Spain (2)  ·  Ukraine (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)

Top investigators

Aaron Milstone, MD MHS (1)  ·  Alexandre Biasi, MD/PhD (1)  ·  Antoni Torres, MD PhD (1)  ·  Avery B Nathens, MD PhD MPH (1)  ·  Cindy L Munro, RN,ANP,PHD (1)  ·  Cindy Munro, RN, ANP,PhD (1)  ·  Daniel E Freedberg, MD, MS (1)  ·  Deborah J Cook, MD (1)  ·  Evangelos Giamarellos-Bourboulis, MD PhD (1)  ·  Evangelos Giamarellos-Bourboulis, MD, PhD (1)  ·  Frank A. Scannapieco, DMD PhD (1)  ·  Greg Martin, MD, MSc (1)  ·  Guillermo Umpierrez, MD (1)  ·  Hazem E Elsersy, MD (1)  ·  Jean-Jacques Rouby, MD, PhD (1)

Results publications

PMID 16980879, PMID 17076839, PMID 17119142, PMID 18461895, PMID 18991508, PMID 19765321, PMID 22488002, PMID 23363666, PMID 25317722, PMID 27419080, PMID 27480757, PMID 27965798, PMID 28159015, PMID 28186383, PMID 30526610, PMID 32526149, PMID 32595159, PMID 36289153, PMID 37068952, PMID 37947276, PMID 38676438, PMID 39230271, PMID 39806400, PMID 40237647, PMID 41319662, PMID 41552367, PMID 42047567, PMID 42497015

NIH funding

R01NR007652 (2), 2019 (1), P50HL073996 (1), R01DE014685 (1), R33HL138650 (1)